0001213900-25-062768.txt : 20250710 0001213900-25-062768.hdr.sgml : 20250710 20250710160524 ACCESSION NUMBER: 0001213900-25-062768 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250710 DATE AS OF CHANGE: 20250710 EFFECTIVENESS DATE: 20250710 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NLS Pharmaceutics Ltd. CENTRAL INDEX KEY: 0001783036 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-551329 FILM NUMBER: 251116385 BUSINESS ADDRESS: STREET 1: THE CIRCLE 6 STREET 2: 8058 CITY: ZURICH STATE: V8 ZIP: CH-6370 BUSINESS PHONE: 41-41-618-80-00 MAIL ADDRESS: STREET 1: THE CIRCLE 6 STREET 2: 8058 CITY: ZURICH STATE: V8 ZIP: CH-6370 D 1 primary_doc.xml X0708 D LIVE 0001783036 NLS Pharmaceutics Ltd. THE CIRCLE 6 ZURICH V8 SWITZERLAND 8058 +41.44.512.2150 SWITZERLAND None None Other Limited Company true Alexander Zwyer The Circle 6 Zurich V8 SWITZERLAND 8058 Executive Officer Director Chief Executive Officer Ronald Hafner The Circle 6 Zurich V8 SWITZERLAND 8058 Director Chairman of the Board of Directors Nicole Fernandez-McGovern The Circle 6 Zurich V8 SWITZERLAND 8058 Executive Officer Chief Financial Officer Florence Allouche Aknin The Circle 6 Zurich V8 SWITZERLAND 8058 Director Gian-Marco Rinaldi de la Cruz The Circle 6 Zurich V8 SWITZERLAND 8058 Director Olivier Samuel The Circle 6 Zurich V8 SWITZERLAND 8058 Director Pharmaceuticals Decline to Disclose 06b false 2025-06-27 false true true true false 0 1000000 1000000 0 Represents total gross proceeds received by the company in connection with a private placement of preferred participation certificates and warrants. false 3 0 0 0 false NLS Pharmaceutics Ltd. /s/ Alexander Zwyer Alexander Zwyer Chief Executive Officer 2025-07-10